Medical Cannabis
Science-led insight on therapeutic use, formulations, and clinical best practice.
Medical Cannabis · page 4
- Medical Cannabis
Voices of Cannabis Europa: Sasho Stefanoski, CEO of PHCANN International
As we head into Cannabis Europa, Business of Cannabis chats with Sasho Stefanoski, CEO of PHCANN International. 26–27 May 2026 · Barbican, London Cannabis Europa Two days of policy, capital and clinical strategy at the Barbican — convening operators, investors, regulators and clinicians from across the European cannabis market.
- Medical Cannabis
Curaleaf Laboratories Becomes First UK Manufacturer of Medical Cannabis Suppositories and Pessaries
Curaleaf Laboratories Becomes First UK Manufacturer of Medical Cannabis Suppositories and Pessaries Curaleaf Laboratories today announced a significant milestone in the advancement of medical cannabis treatments in the United Kingdom, becoming the first licensed manufacturer in the country to develop and produce medical cannabis suppositories and pessaries.
- Industry Trends
DEA’s Schedule III Cannabis Order: A Free-For-All for Telehealth Platforms, or the Perfect Setup for the Entire Industry?
As the industry’s (more than justified) excitement over last week’s rescheduling announcement begins to subside, the regulatory reality is settling in.
- Industry Trends
Cannabis Europa London 2026: The First Major Gathering Since Rescheduling Changed the Game
For many, last week’s rescheduling announcement threw a spanner in the works.
- Investment & Finance
The Fight for Cannabis Rescheduling Is Far From Over
Last week’s rescheduling announcement came as a surprise to many, not least to us here at Business of Cannabis.
- Industry Trends
Does the UK Media’s Cannabis Coverage Reflect Public Opinion? The Data Says No
This morning, the latest in a now-weekly series of stories in the British mainstream press was published in The Times, for the second week in a row taking aim at the advertising practices of some of the UK’s largest clinics.
- International Regulation
Cannabis Industry Council Releases Global Guide for Patients Travelling with Medical Cannabis
The UK’s Cannabis Industry Council (CIC) has published a new comprehensive guide for patients travelling with prescribed medical cannabis in the wake of a series of reported incidents involving both airlines and border control authorities.
- Interviews
Bring It On: Meet the Cannabis CMO Welcoming Scrutiny With Open Arms
Scrutiny of the UK’s medical cannabis industry has rarely, if ever, been so acute since it was legalised in 2018.
- Industry Trends
Is Spain Set to Become the Next European Cannabis Processing Hub?
As the European medical cannabis market has developed, expanded and matured over the last half-decade, Portugal has played a critical role in the global supply chain, earning a reputation as the ‘doorway to Europe’.
- Medical Cannabis
The Right Reforms, the Wrong Narrative: Why the Medical Cannabis Debate Is Missing Half the Picture
Over the last few weeks, the UK’s medical cannabis industry has been written about in The Times, The Guardian, the BBC, The i Paper, Private Eye, and a swathe of other national and local publications.
- Medical Cannabis
Five Years, 74 Patients: Ireland Moves Forward With Review of Its Failing Medical Cannabis Programme
The Irish government has appointed a public health academic to chair a formal review of its now five-year-old Medical Cannabis Access Programme (MCAP) following months of parliamentary pressure.
- Medical Cannabis
Oliver’s Law: The Campaign That Could Reshape UK Cannabis Prescribing
Written by Ben Stevens & Sarah Sinclair A new campaign is calling for urgent regulatory changes to how medical cannabis is prescribed to patients in the UK, following what is believed to be the first time a coroner has found that a prescription for cannabis contributed to a death in the country.
